Jamie R. Wagner

5.1k citations

28 papers · 1.8k indexed · 1 hit paper · h-index 11

Co-authors: Michael C. Jensen Christine L. Wright Araceli Naranjo Wen-Chung Chang Christine E. Brown Julie R. Ostberg Stephen J. Forman Behnam Badie
Topics: CAR-T cell therapy research (25 papers)Immunotherapy and Immune Responses (5 papers)Virus-based gene therapy research (3 papers)
Cited by: Oncology Immunology Genetics
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations: United States

In The Last Decade

Jamie R. Wagner

27 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

2015 592 citations Christine E. Brown, Behnam Badie et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Jamie R. Wagner

Since Specialization

Citations

This map shows the geographic impact of Jamie R. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie R. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie R. Wagner more than expected).

Fields of papers citing papers by Jamie R. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie R. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie R. Wagner. The network helps show where Jamie R. Wagner may publish in the future.

Co-authorship network of co-authors of Jamie R. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie R. Wagner. A scholar is included among the top collaborators of Jamie R. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie R. Wagner. Jamie R. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety 2025 ·Cell Reports Medicine ·Michael E. Barish,Maryam Aftabizadeh,(unknown),M. Suzette Blanchard,Julie R. Ostberg,Jamie R. Wagner,(unknown),Jinny Paul,(unknown),Brenda Aguilar,Renate Starr,Leonidas Arvanitis,Julie A. Ressler,Julie Kilpatrick,Yichun Kong,Dongrui Wang,Stephen J. Forman,Massimo D’Apuzzo,Christine E. Brown,Behnam Badie	2
2	First-in-human trial of allogeneic CD6-CAR tregs in patients with chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation 2025 ·Blood ·Amandeep Salhotra,Jamie R. Wagner,Dongyun Yang,Haris Ali,Salman Otoukesh,(unknown),Sindhu Saraswathy,(unknown),Dileshni Tilakawardane,Sunmin Park,Stephen J. Forman,(unknown),Christine E. Brown,Enrique Montero	0
3	1525 Initial clinical experience with chlorotoxin-redirected CAR T cells for patients with recurrent glioblastoma 2023 ·SHILAP Revista de lepidopterología ·Maryam Aftabizadeh,(unknown),Tracey Stiller,Heini M. Natri,Brenda Aguilar,Jamie R. Wagner,Jinny Paul,Renate Starr,Julie A. Ressler,Julie Kilpatrick,(unknown),Massimo D’Apuzzo,(unknown),Stephen J. Forman,Michael E. Barish,Behnam Badie,Christine E. Brown	1
4	Favorable Activity of CD19-Targeted Chimeric Antigen Receptor (CD19CAR) T Cell Therapy in Adults with Relapsed/ Refractory (R/R) ALL Including Extramedullary Disease (EMD) and Ph-like Genotype, Using Naive/Memory (Tn/ Mem) Derived T Cells 2022 ·Transplantation and Cellular Therapy ·Ibrahim Aldoss,Samer K. Khaled,M. Suzette Blanchard,Xiuli Wang,Jamie R. Wagner,Mary Ann Clark,Jennifer Simpson,Jinny Paul,Anthony S. Stein,Vinod Pullarkat,Amandeep Salhotra,Monzr M. Al Malki,Sandra P. Thomas,Lihua E. Budde,Guido Marcucci,Christine E. Brown,Stephen J. Forman	1
5	Abstract CT541A: Oncolytic viral reshaping of the tumor microenvironment to promote CAR T cell therapy for glioblastoma 2022 ·Cancer Research ·Christine E. Brown,(unknown),(unknown),(unknown),Brenda Aguilar,Jamie R. Wagner,Bruce J. Dezube,Knut Niß,(unknown),(unknown),Jianmei W. Leavenworth,Stephen J. Forman,Behnam Badie,James M. Markert,Kevin A. Cassady	1
6	Phase 1 study of PSCA-targeted chimeric antigen receptor (CAR) T cell therapy for metastatic castration-resistant prostate cancer (mCRPC). 2022 ·Journal of Clinical Oncology ·Tanya B. Dorff,Suzette Blanchard,(unknown),(unknown),(unknown),(unknown),Jamie R. Wagner,Ammar Chaudhry,Massimo D’Apuzzo,Peter Kühn,Stephen J. Forman,Saul J. Priceman	16
7	A phase 1 study to evaluate chimeric antigen receptor (CAR) T cells incorporating a chlorotoxin tumor-targeting domain for patients with MMP2+ Recurrent or progressive glioblastoma (NCT04214392). 2021 ·Journal of Clinical Oncology ·Behnam Badie,Michael E. Barish,Ammar Chaudhry,Massimo D’Apuzzo,Stephen J. Forman,Jana Portnow,Shirong Wang,Julie A. Ressler,Jennifer Simpson,Julie Kilpatrick,(unknown),Jamie R. Wagner,Suzette Blanchard,Dongrui Wang,Christine E. Brown	9
8	Results from a Phase 1 Study to Evaluate a Memory-Enriched CD19-Specific CAR T Cell Platform in Adult Patients with CD19+ B-Cell Non-Hodgkin Lymphoma (B-NHL) 2021 ·Blood ·Tanya Siddiqi,Xiuli Wang,M. Suzette Blanchard,Jamie R. Wagner,Vibhuti Vyas,Mary C. Clark,Sandra H. Thomas,(unknown),(unknown),Leslie Popplewell,Alex F. Herrera,Elizabeth Budde,Liana Nikolaenko,Christine E. Brown,Stephen J. Forman	1
9	Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program 2020 ·Biology of Blood and Marrow Transplantation ·(unknown),(unknown),Jamie R. Wagner,Mary C. Clark,Brenda Chang,(unknown),(unknown),(unknown),Joseph Rosenthal,Eileen Smith,Stephen J. Forman,David S. Snyder,Lihua E. Budde	9
10	A phase I study to evaluate PSCA-targeting chimeric antigen receptor (CAR)-T cells for patients with PSCA+ metastatic castration-resistant prostate cancer (mCRPC). 2020 ·Journal of Clinical Oncology ·Tanya B. Dorff,Suzette Blanchard,(unknown),Jamie R. Wagner,Peter Kühn,Ammar Chaudhry,(unknown),Sandra H. Thomas,(unknown),Peiguo Chu,Sumanta K. Pal,Stephen J. Forman,Saul J. Priceman	9
11	Adult Patients with ALL Treated with CD62L+ T Naïve/Memory-Enriched T Cells Expressing a CD19-CAR Mediate Potent Antitumor Activity with a Low Toxicity Profile 2018 ·Blood ·Samer K. Khaled,Suzette Blanchard,Xiuli Wang,Jamie R. Wagner,Araceli Naranjo,Jennifer Simpson,Sandra H. Thomas,Julie R. Ostberg,Christine E. Brown,Stephen J. Forman	7
12	Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma 2017 ·Science Translational Medicine ·Khun Visith Keu,Timothy H. Witney,Shahriar Yaghoubi,Jarrett Rosenberg,(unknown),(unknown),John Williams,Frezghi Habte,Jamie R. Wagner,Stephen J. Forman,Christine E. Brown,Martin Allen-Auerbach,Johannes Czernin,Winson W. Tang,Michael C. Jensen,Behnam Badie,Sanjiv S. Gambhir	247
13	ATIM-13. PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T CELLS TARGETING IL13Rα2 FOR THE TREATMENT OF GLIOBLASTOMA 2016 ·Neuro-Oncology ·Christine E. Brown,Darya Alizadeh,Renate Starr,Lihong Weng,Jamie R. Wagner,Araceli Naranjo,Suzette Blanchard,Julie Kilpatrick,Jennifer Simpson,Julie A. Ressler,Michael C. Jensen,Jana Portnow,Massimo D’Apuzzo,Michael E. Barish,Stephen J. Forman,Behnam Badie	3
14	Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastomabreakdown → 2015 ·Clinical Cancer Research ·Christine E. Brown,Behnam Badie,Michael E. Barish,Lihong Weng,Julie R. Ostberg,Wen-Chung Chang,Araceli Naranjo,Renate Starr,Jamie R. Wagner,Christine L. Wright,Yubo Zhai,James R. Bading,Julie A. Ressler,Jana Portnow,Massimo D’Apuzzo,Stephen J. Forman,Michael C. Jensen	592
15	Phase I Studies of Cellular Immunotherapy Using Central Memory Derived-CD19-Specific T Cells Following Autologous Stem Cell Transplantation for Patients with High-Risk Intermediate Grade B-Lineage Non-Hodgkin Lymphoma 2015 ·Blood ·Leslie Popplewell,Xiuli Wang,Araceli Naranjo,Suzette Blanchard,Jamie R. Wagner,(unknown),Ryan Urak,Wen-Chung Chang,Samer K. Khaled,Tanya Siddiqi,Elizabeth Budde,Jingying Xu,Brenda Chang,Sandra H. Thomas,Stanley R. Riddell,Christine E. Brown,Michael C. Jensen,Stephen J. Forman	3
16	Manufacturing of Large Numbers of Patient-specific T Cells for Adoptive Immunotherapy 2007 ·Journal of Immunotherapy ·(unknown),Luciana Burton,(unknown),Jamie R. Wagner,Michael C. Jensen,Stephen J. Forman,David DiGiusto	30
17	Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma 2007 ·Molecular Therapy ·Julie R. Park,David DiGiusto,Marilyn L. Slovak,Christine L. Wright,Araceli Naranjo,Jamie R. Wagner,(unknown),(unknown),Wen-Chung Chang,Julie R. Ostberg,Michael C. Jensen	474
18	Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor 2006 ·Cancer Gene Therapy ·(unknown),(unknown),Bessie Meechoovet,Jamie R. Wagner,Brenda Aguilar,Christine L. Wright,Wei‐Chin Chang,Christine E. Brown,Michael C. Jensen	47
19	Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing 2005 ·Journal of Immunological Methods ·Christine E. Brown,Christine L. Wright,Araceli Naranjo,(unknown),Wen-Chung Chang,Simon Olivares,Jamie R. Wagner,Laura A. Bruins,Andrew Raubitschek,Laurence J.N. Cooper,Michael C. Jensen	59
20	A quantitative high-throughput chemotaxis assay using bioluminescent reporter cells 2005 ·Journal of Immunological Methods ·(unknown),Christine E. Brown,Jamie R. Wagner,(unknown),Araceli Naranjo,Christine L. Wright,Simon Olivares,Dajun Qian,Laurence J.N. Cooper,Michael C. Jensen	10

About Jamie R. Wagner

Jamie R. Wagner is a scholar working on Oncology, Structural Biology and Immunology, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (25 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (625 citations) and Genetics (250 citations). Jamie R. Wagner has collaborated with scholars based in United States. Frequent co-authors include Michael C. Jensen, Christine L. Wright, Araceli Naranjo, Wen-Chung Chang, Christine E. Brown, Julie R. Ostberg, Stephen J. Forman, Behnam Badie, David DiGiusto and Lihong Weng. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact